Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-038689
Filing Date
2015-05-15
Accepted
2015-05-15 16:06:39
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7901_110q.htm 10-Q 584436
2 EX-31.1 a15-7901_1ex31d1.htm EX-31.1 11436
3 EX-31.2 a15-7901_1ex31d2.htm EX-31.2 11393
4 EX-32.1 a15-7901_1ex32d1.htm EX-32.1 6022
5 EX-32.2 a15-7901_1ex32d2.htm EX-32.2 5981
  Complete submission text file 0001104659-15-038689.txt   4031086

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20150331.xml EX-101.INS 473924
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20150331.xsd EX-101.SCH 39335
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20150331_cal.xml EX-101.CAL 37213
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20150331_def.xml EX-101.DEF 118838
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20150331_lab.xml EX-101.LAB 371855
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20150331_pre.xml EX-101.PRE 237368
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 15869279
SIC: 2834 Pharmaceutical Preparations